Trials / Completed
CompletedNCT01400945
Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease
Double Blinded, Randomized, Active Drug Comparative, Therapeutic Confirmatory Clinical Study to Evaluate the Efficacy and Safety of AGSPT201 in GERD Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 154 (actual)
- Sponsor
- Ahn-Gook Pharmaceuticals Co.,Ltd · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate treatment in Gastroesophageal Reflux Disease (GERD) patients (aged 18\~75) with endoscopically proven GERD treated with AGSPT201 Tablet.
Detailed description
This study is 4,8 weeks, outpatient, multicenter, randomized, double-blinded, active drug comparative, therapeutic confirmatory clinical study to evaluate the efficacy and safety of AGSPT201 in erosive esophagitis patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AGSPT201 Tab contains S-pantoprazole | comparison of Pantoloc Tab 40mg |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2011-08-01
- Completion
- 2011-09-01
- First posted
- 2011-07-25
- Last updated
- 2011-09-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01400945. Inclusion in this directory is not an endorsement.